Home > Products > EGFR & CD89 > Recombinant Human Anti-EGFR x Anti-CD89 Bispecific Antibody (Single-chain Triplebody)

Recombinant Human Anti-EGFR x Anti-CD89 Bispecific Antibody (Single-chain Triplebody)  (CAT#: SCTB-H194)

Recombinant Anti-EGFR x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) is designed to be expressed as a single chain with three scFv units, two distal binding sites for EGFR and a central site for CD89 . It contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
Datasheet INQUIRY

Specifications

Targets
EGFR & CD89
Type
Single-chain Triplebody
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC)Solid tumors

Targets

Target 1
EGFR
Gene ID
UniProt ID
Alternative Names
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; erb-b2 receptor tyrosine kinase 1; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog
Target 2
CD89
Gene ID
UniProt ID
Alternative Names
FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-EGFR x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) (SCTB-H194). Click the button below to contact us or submit your feedback about this product.